Ontario is the first province in Canada to offer public reimbursement for Pluvicto™, a targeted radioligand therapy for patients with progressive PSMA-positive metastatic castration-resistant prostate ...

Scottish Medicines Consortium (SMC) has recommended Fabhalta® (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the ...

Explore opportunities with Novartis below.

Job Title Sort ascending Business Location Site Date Posted Sr. Spec. DDIT IES O365 Sec. & Compl. Regular, Full time CTS India Hyderabad (Office) Jan 16, 2025 Sr. Spec. DDIT ISC Gov Digital Regular, ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

At Novartis, we have a strong commitment to sustainable development. As a global organization, we recognize the opportunity to drive positive social change. We are on a continuous journey to channel ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

To advance the work we do for and with communities, we look to connect with experts and listen to diverse voices. From patients and care partners to health care teams, hearing from all individuals ...

Key Account Executive-4 CDI (Ventes), Full time Innovative Medicines Hong Kong Special Administrative Region, China Hong Kong Jan 06, 2025 县域主任/县域主管 ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...